Compare Organon & Co. Common Stock (OGN) vs Restaurant Brands International Inc. Common Shares (QSR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon & Co. Common Stock vs Restaurant Brands International Inc. Common Shares — how do they compare? Organon & Co. Common Stock trades at $13.58 (market cap $3.62B), while Restaurant Brands International Inc. Common Shares trades at $73.03 (market cap $24.77B). The key difference: Restaurant Brands International Inc. Common Shares is far larger — about 6.8× Organon & Co. Common Stock's market cap, and Restaurant Brands International Inc. Common Shares pays the higher dividend (3.65%). Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and Restaurant Brands International Inc. Common Shares for 6 Days on average.
| OGN | QSR | |
|---|---|---|
Market Cap | $3.62B | $24.77B |
Volume | 2,892,999 | 3,180,422 |
Sector | Health | Consumer Cyclical |
52-Week High | $13.81 | $81.67 |
52-Week Low | $5.70 | $65.69 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $11.04B | $39.38B |
Dividend Yield | 0.58% | 3.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
QSR trades at $71.27, up 0.21% on the day, with a bearish technical signal driven by moving averages and oscillators. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.08. Revenue reached $9.43B in 2025, with net income of $776M, and is projected to grow to $9.7B in 2026. Analyst consensus is bullish with a price target of $84.80, supported by Burger King's turnaround momentum noted in recent news.
The outlook for QSR is positive due to strong earnings performance and analyst optimism, but near-term technical weakness and competitive pressures pose risks. Investment opportunity lies in execution of the Burger King revitalization and franchise strategy, while risks include market volatility and execution gaps in value offerings against rivals like McDonald's.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →About Restaurant Brands International Inc. Common Shares
Restaurant Brands International owns and franchises quick-service restaurant brands, including Burger King, Tim Hortons, Popeyes, and Firehouse Subs.
Read more on QSR →
